We are live on
!
Find out more
CI
Chartist Inc Portfolio holdings
AUM
$139M
This Fund
S&P 500
This Quarter
Est. Return
-0.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
-$3.62M
(-1.7%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
6.16%
Top 10 Holdings %
Top 10 Hldgs %
61.4%
Holding
42
New
1
Increased
4
Reduced
23
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$56.2M |
| 2 |
AGN
Allergan Inc
AGN
|
+$4.69M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$180 |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$43 |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$34 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$4.49M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$244K |
| 3 |
ISD
PGIM High Yield Bond Fund
ISD
|
+$212K |
| 4 |
State Street SPDR S&P Homebuilders ETF
XHB
|
+$143K |
| 5 |
iShares US Transportation ETF
IYT
|
+$127K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 21.13% |
| 2 | Consumer Discretionary | 6.12% |
| 3 | Communication Services | 4.83% |
| 4 | Financials | 3.22% |
| 5 | Healthcare | 2.53% |
Similar funds
BCCM
BCA
LIP
SMCM
KLCM
CFWMA
STA
ACP
Chartist Inc's Q2 2015 Portfolio in Review
As of Q2 2015, Chartist Inc held 42 positions worth $207M, down 1.7% from $211M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Chartist Inc deployed $12.8M of net new capital in Q2 2015, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Allergan Inc: 15,248 shares worth $4.69M.
By sector, the portfolio is most concentrated in Materials at 21% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $244K trimmed.
- Chartist Inc's largest Q2 2015 buy was Allergan Inc: 15,248 shares worth $4.69M.
- Chartist Inc added most to Sherwin-Williams in Q2 2015, an estimated $56.2M increase.
- Chartist Inc's biggest Q2 2015 reduction was iShares Biotechnology ETF, cutting an estimated $244K.
- Chartist Inc fully exited Allergan plc in Q2 2015, selling an estimated $4.49M.
- Chartist Inc's ten largest holdings make up 61% of its $207M portfolio in Q2 2015.
- Chartist Inc opened 1 new position and closed 3 in Q2 2015.
- Chartist Inc's portfolio value fell 1.7% quarter-over-quarter to $207M.
Based on Chartist Inc's 13F filing for Q2 2015, filed 17 Jul 2015.